The role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts

Shuang Liang, Tatiana Kisseleva, David A. Brenner

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

Chronic liver injury, resulted from different etiologies (e.g., virus infection, alcohol abuse, nonalcoholic steatohepatitis (NASH) and cholestasis) can lead to liver fibrosis characterized by the excess accumulation of extracellular matrix (ECM) proteins (e.g., type I collagen). Hepatic myofibroblasts that are activated upon liver injury are the key producers of ECM proteins, contributing to both the initiation and progression of liver fibrosis. Hepatic stellate cells (HSCs) and to a lesser extent, portal fibroblast, are believed to be the precursor cells that give rise to hepatic myofibroblasts in response to liver injury. Although, much progress has been made toward dissecting the lineage origin of myofibroblasts, how these cells are activated and become functional producers of ECM proteins remains incompletely understood. Activation of myofibroblasts is a complex process that involves the interactions between parenchymal and non-parenchymal cells, which drives the phenotypic change of HSCs from a quiescent stage to a myofibroblastic and active phenotype. Accumulating evidence has suggested a critical role of NADPH oxidase (NOX), a multi-component complex that catalyzes reactions from molecular oxygen to reactive oxygen species (ROS), in the activation process of hepatic myofibroblasts. NOX isoforms, including NOX1, NOX2 and NOX4, and NOX-derived ROS, have all been implicated to regulate HSC activation and hepatocyte apoptosis, both of which are essential steps for initiating liver fibrosis. This review highlights the importance of NOX isoforms in hepatic myofibroblast activation and the progression of liver fibrosis, and also discusses the therapeutic potential of targeting NOXs for liver fibrosis and associated hepatic diseases.

Original languageEnglish (US)
Article number17
JournalFrontiers in Physiology
Volume7
Issue numberFEB
DOIs
StatePublished - Feb 2 2016
Externally publishedYes

Fingerprint

Myofibroblasts
NADPH Oxidase
Liver Cirrhosis
Liver
Hepatic Stellate Cells
Extracellular Matrix Proteins
Reactive Oxygen Species
Wounds and Injuries
Protein Isoforms
Cholestasis
Virus Diseases
Collagen Type I
Alcoholism
Hepatocytes
Fibroblasts
Apoptosis
Oxygen
Phenotype

Keywords

  • Hepatic stellate cells (HSCs)
  • Hepatocytes
  • Liver fibrosis
  • Myofibroblasts
  • NADPH oxidase (NOX)
  • Reactive oxygen species (ROS)

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

The role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts. / Liang, Shuang; Kisseleva, Tatiana; Brenner, David A.

In: Frontiers in Physiology, Vol. 7, No. FEB, 17, 02.02.2016.

Research output: Contribution to journalReview article

@article{fd8c2228c5ab4f339a0f29d928a58f5c,
title = "The role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts",
abstract = "Chronic liver injury, resulted from different etiologies (e.g., virus infection, alcohol abuse, nonalcoholic steatohepatitis (NASH) and cholestasis) can lead to liver fibrosis characterized by the excess accumulation of extracellular matrix (ECM) proteins (e.g., type I collagen). Hepatic myofibroblasts that are activated upon liver injury are the key producers of ECM proteins, contributing to both the initiation and progression of liver fibrosis. Hepatic stellate cells (HSCs) and to a lesser extent, portal fibroblast, are believed to be the precursor cells that give rise to hepatic myofibroblasts in response to liver injury. Although, much progress has been made toward dissecting the lineage origin of myofibroblasts, how these cells are activated and become functional producers of ECM proteins remains incompletely understood. Activation of myofibroblasts is a complex process that involves the interactions between parenchymal and non-parenchymal cells, which drives the phenotypic change of HSCs from a quiescent stage to a myofibroblastic and active phenotype. Accumulating evidence has suggested a critical role of NADPH oxidase (NOX), a multi-component complex that catalyzes reactions from molecular oxygen to reactive oxygen species (ROS), in the activation process of hepatic myofibroblasts. NOX isoforms, including NOX1, NOX2 and NOX4, and NOX-derived ROS, have all been implicated to regulate HSC activation and hepatocyte apoptosis, both of which are essential steps for initiating liver fibrosis. This review highlights the importance of NOX isoforms in hepatic myofibroblast activation and the progression of liver fibrosis, and also discusses the therapeutic potential of targeting NOXs for liver fibrosis and associated hepatic diseases.",
keywords = "Hepatic stellate cells (HSCs), Hepatocytes, Liver fibrosis, Myofibroblasts, NADPH oxidase (NOX), Reactive oxygen species (ROS)",
author = "Shuang Liang and Tatiana Kisseleva and Brenner, {David A.}",
year = "2016",
month = "2",
day = "2",
doi = "10.3389/fphys.2016.00017",
language = "English (US)",
volume = "7",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",
number = "FEB",

}

TY - JOUR

T1 - The role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts

AU - Liang, Shuang

AU - Kisseleva, Tatiana

AU - Brenner, David A.

PY - 2016/2/2

Y1 - 2016/2/2

N2 - Chronic liver injury, resulted from different etiologies (e.g., virus infection, alcohol abuse, nonalcoholic steatohepatitis (NASH) and cholestasis) can lead to liver fibrosis characterized by the excess accumulation of extracellular matrix (ECM) proteins (e.g., type I collagen). Hepatic myofibroblasts that are activated upon liver injury are the key producers of ECM proteins, contributing to both the initiation and progression of liver fibrosis. Hepatic stellate cells (HSCs) and to a lesser extent, portal fibroblast, are believed to be the precursor cells that give rise to hepatic myofibroblasts in response to liver injury. Although, much progress has been made toward dissecting the lineage origin of myofibroblasts, how these cells are activated and become functional producers of ECM proteins remains incompletely understood. Activation of myofibroblasts is a complex process that involves the interactions between parenchymal and non-parenchymal cells, which drives the phenotypic change of HSCs from a quiescent stage to a myofibroblastic and active phenotype. Accumulating evidence has suggested a critical role of NADPH oxidase (NOX), a multi-component complex that catalyzes reactions from molecular oxygen to reactive oxygen species (ROS), in the activation process of hepatic myofibroblasts. NOX isoforms, including NOX1, NOX2 and NOX4, and NOX-derived ROS, have all been implicated to regulate HSC activation and hepatocyte apoptosis, both of which are essential steps for initiating liver fibrosis. This review highlights the importance of NOX isoforms in hepatic myofibroblast activation and the progression of liver fibrosis, and also discusses the therapeutic potential of targeting NOXs for liver fibrosis and associated hepatic diseases.

AB - Chronic liver injury, resulted from different etiologies (e.g., virus infection, alcohol abuse, nonalcoholic steatohepatitis (NASH) and cholestasis) can lead to liver fibrosis characterized by the excess accumulation of extracellular matrix (ECM) proteins (e.g., type I collagen). Hepatic myofibroblasts that are activated upon liver injury are the key producers of ECM proteins, contributing to both the initiation and progression of liver fibrosis. Hepatic stellate cells (HSCs) and to a lesser extent, portal fibroblast, are believed to be the precursor cells that give rise to hepatic myofibroblasts in response to liver injury. Although, much progress has been made toward dissecting the lineage origin of myofibroblasts, how these cells are activated and become functional producers of ECM proteins remains incompletely understood. Activation of myofibroblasts is a complex process that involves the interactions between parenchymal and non-parenchymal cells, which drives the phenotypic change of HSCs from a quiescent stage to a myofibroblastic and active phenotype. Accumulating evidence has suggested a critical role of NADPH oxidase (NOX), a multi-component complex that catalyzes reactions from molecular oxygen to reactive oxygen species (ROS), in the activation process of hepatic myofibroblasts. NOX isoforms, including NOX1, NOX2 and NOX4, and NOX-derived ROS, have all been implicated to regulate HSC activation and hepatocyte apoptosis, both of which are essential steps for initiating liver fibrosis. This review highlights the importance of NOX isoforms in hepatic myofibroblast activation and the progression of liver fibrosis, and also discusses the therapeutic potential of targeting NOXs for liver fibrosis and associated hepatic diseases.

KW - Hepatic stellate cells (HSCs)

KW - Hepatocytes

KW - Liver fibrosis

KW - Myofibroblasts

KW - NADPH oxidase (NOX)

KW - Reactive oxygen species (ROS)

UR - http://www.scopus.com/inward/record.url?scp=84962703216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962703216&partnerID=8YFLogxK

U2 - 10.3389/fphys.2016.00017

DO - 10.3389/fphys.2016.00017

M3 - Review article

C2 - 26869935

AN - SCOPUS:84962703216

VL - 7

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

IS - FEB

M1 - 17

ER -